With a strong background in healthcare investments, the fund manager boasts extensive experience in identifying and nurturing innovative companies across Europe and North America. Having successfully completed over 50 deals, the focus lies on growth-stage investments that emphasize operator-first strategies. The portfolio includes notable exits in biotechnology and medical devices, showcasing a commitment to data-driven decision-making. This strategic approach enables the manager to capitalize on emerging trends and foster value creation within the sector.